178 related articles for article (PubMed ID: 2655530)
1. In vitro antibacterial activity of SM-7338, a carbapenem antibiotic with stability to dehydropeptidase I.
Edwards JR; Turner PJ; Wannop C; Withnell ES; Grindey AJ; Nairn K
Antimicrob Agents Chemother; 1989 Feb; 33(2):215-22. PubMed ID: 2655530
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338.
Neu HC; Novelli A; Chin NX
Antimicrob Agents Chemother; 1989 Jul; 33(7):1009-18. PubMed ID: 2789493
[TBL] [Abstract][Full Text] [Related]
3. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
Chanal C; Sirot D; Chanal M; Cluzel M; Sirot J; Cluzel R
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():133-41. PubMed ID: 2808205
[TBL] [Abstract][Full Text] [Related]
4. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
Edwards JR
New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
Ubukata K; Hikida M; Yoshida M; Nishiki K; Furukawa Y; Tashiro K; Konno M; Mitsuhashi S
Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313
[TBL] [Abstract][Full Text] [Related]
6. Multicenter in vitro evaluation of SM-7338, a new carbapenem.
Jones RN; Aldridge KE; Allen SD; Barry AL; Fuchs PC; Gerlach EH; Pfaller MA
Antimicrob Agents Chemother; 1989 Apr; 33(4):562-5. PubMed ID: 2658796
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial in vitro-activity of meropenem against 200 clinical isolates in comparison to 11 selected antibiotics.
Lang C; Beuth J; Ko HL; Tunggal L; Pulverer G
Zentralbl Bakteriol; 1992 Dec; 277(4):485-92. PubMed ID: 1303691
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.
Schito GC; Sanna A; Chezzi C; Ravizzola G; Leone F; Molinari G; Menozzi MG; Pirali F
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338.
Sumita Y; Inoue M; Mitsuhashi S
Eur J Clin Microbiol Infect Dis; 1989 Oct; 8(10):908-16. PubMed ID: 2512140
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
Fukuoka T; Ohya S; Utsui Y; Domon H; Takenouchi T; Koga T; Masuda N; Kawada H; Kakuta M; Kubota M; Ishii C; Ishii C; Sakagawa E; Harasaki T; Hirasawa A; Abe T; Yasuda H; Iwata M; Kuwahara S
Antimicrob Agents Chemother; 1997 Dec; 41(12):2652-63. PubMed ID: 9420035
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of BMS-181139, a new carbapenem with potent antipseudomonal activity.
Kessler RE; Fung-Tomc J; Kolek B; Minassian B; Huczko E; Gradelski E; Bonner DP
Antimicrob Agents Chemother; 1995 Feb; 39(2):380-5. PubMed ID: 7726502
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
Sader HS; Jones RN
Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):384-91. PubMed ID: 8354307
[TBL] [Abstract][Full Text] [Related]
13. The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics.
Neu HC; Chin NX; Labthavikul P
J Antimicrob Chemother; 1985 Sep; 16(3):305-13. PubMed ID: 2997100
[TBL] [Abstract][Full Text] [Related]
14. Comparative in-vitro activity of meropenem on clinical isolates from the United Kingdom.
King A; Boothman C; Phillips I
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():31-45. PubMed ID: 2808214
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
Petersen PJ; Jacobus NV; Weiss WJ; Testa RT
Antimicrob Agents Chemother; 1991 Jan; 35(1):203-7. PubMed ID: 1901698
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of the new carbapenem meropenem (SM-7338) against clinical isolates.
Ravizzola G; Pinsi G; Gonzales R; Colombrita D; Pirali F; Turano A
Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1053-61. PubMed ID: 2620673
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus.
Sumita Y; Nouda H; Kanazawa K; Fukasawa M
Antimicrob Agents Chemother; 1995 Apr; 39(4):910-6. PubMed ID: 7785994
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin.
Neu HC; Chin NX; Huang HB
Antimicrob Agents Chemother; 1993 Mar; 37(3):566-73. PubMed ID: 8460925
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity.
Nakagawa S; Hashizume T; Matsuda K; Sanada M; Okamoto O; Fukatsu H; Tanaka N
Antimicrob Agents Chemother; 1993 Dec; 37(12):2756-9. PubMed ID: 8109950
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of meropenem against clinical isolates obtained in Canada.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():47-55. PubMed ID: 2808216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
